Protagonist Therapeutics (PTGX) IPO Opened Flat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
UPDATE: Protagonist Therapeutics (PTGX) Prices 7.5M Common Stock IPO at $12/Share, Flat with Expectations
August 11, 2016 6:33 AM EDT(Updated - August 11, 2016 8:58 AM EDT)
Protagonist Therapeutics, Inc. (Nasdaq: PTGX) announced the pricing of its initial public offering of 7,500,000 shares of common stock, at a price to the public of $12 per share, before underwriting discounts and commissions. The shares are expected to begin trading on The NASDAQ Global Market on August 11, 2016, under the symbol "PTGX." In addition, Protagonist has granted the... More



